Marek Zembala

9.4k total citations · 1 hit paper
200 papers, 7.6k citations indexed

About

Marek Zembala is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Marek Zembala has authored 200 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Immunology, 33 papers in Molecular Biology and 32 papers in Oncology. Recurrent topics in Marek Zembala's work include Immune Cell Function and Interaction (57 papers), Immune Response and Inflammation (51 papers) and T-cell and B-cell Immunology (37 papers). Marek Zembala is often cited by papers focused on Immune Cell Function and Interaction (57 papers), Immune Response and Inflammation (51 papers) and T-cell and B-cell Immunology (37 papers). Marek Zembala collaborates with scholars based in Poland, United Kingdom and Italy. Marek Zembala's co-authors include G L Asherson, Jarosław Baran, J Pryjma, Maciej Siedlar, Monika Baj‐Krzyworzeka, Danuta Kowalczyk, Kazimierz Węglarczyk, Vittorio Colizzi, Rafał Szatanek and Loems Ziegler‐Heitbrock and has published in prestigious journals such as Nature, The Journal of Experimental Medicine and Blood.

In The Last Decade

Marek Zembala

196 papers receiving 7.0k citations

Hit Papers

Nomenclature of monocytes and dendritic cells in blood 2010 2026 2015 2020 2010 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Zembala Poland 45 4.4k 1.9k 1.0k 897 766 200 7.6k
Larry M. Wahl United States 47 2.9k 0.7× 1.9k 1.0× 985 1.0× 987 1.1× 1.1k 1.4× 111 7.5k
Koji Matsushima Japan 42 3.5k 0.8× 1.4k 0.7× 1.8k 1.8× 687 0.8× 549 0.7× 105 6.4k
Junming Le United States 29 3.0k 0.7× 1.2k 0.6× 966 0.9× 999 1.1× 350 0.5× 61 5.9k
Jean‐Yves Bonnefoy France 54 6.1k 1.4× 2.3k 1.2× 1.3k 1.3× 1.3k 1.5× 659 0.9× 152 10.5k
M Howard United States 31 6.2k 1.4× 1.4k 0.8× 1.4k 1.4× 1.3k 1.4× 345 0.5× 50 9.3k
Lucien A. Aarden Netherlands 45 4.4k 1.0× 2.4k 1.2× 1.2k 1.2× 1.1k 1.2× 629 0.8× 101 9.1k
Irina A. Udalova United Kingdom 43 3.9k 0.9× 1.9k 1.0× 864 0.8× 1.0k 1.1× 964 1.3× 93 6.8k
Andrew C. Issekutz Canada 54 3.1k 0.7× 2.0k 1.1× 718 0.7× 610 0.7× 367 0.5× 184 7.7k
Pieter J. M. Leenen Netherlands 49 5.4k 1.2× 2.4k 1.2× 1.1k 1.1× 1.1k 1.2× 481 0.6× 173 9.7k
Fabio Re United States 36 4.2k 1.0× 2.7k 1.4× 648 0.6× 897 1.0× 500 0.7× 51 7.2k

Countries citing papers authored by Marek Zembala

Since Specialization
Citations

This map shows the geographic impact of Marek Zembala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Zembala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Zembala more than expected).

Fields of papers citing papers by Marek Zembala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Zembala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Zembala. The network helps show where Marek Zembala may publish in the future.

Co-authorship network of co-authors of Marek Zembala

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Zembala. A scholar is included among the top collaborators of Marek Zembala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Zembala. Marek Zembala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stec, Małgorzata, Jarosław Baran, Rafał Szatanek, et al.. (2012). Properties of monocytes generated from haematopoietic CD34+ stem cells from bone marrow of colon cancer patients. Cancer Immunology Immunotherapy. 62(4). 705–713. 4 indexed citations
2.
Goździk, Jolanta, et al.. (2011). Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease—Single Centre Experience. Journal of Clinical Immunology. 31(3). 332–337. 14 indexed citations
3.
Baran, Jarosław, Monika Baj‐Krzyworzeka, Kazimierz Węglarczyk, et al.. (2009). Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunology Immunotherapy. 59(6). 841–850. 216 indexed citations
4.
Jędrychowski, Wiesław, U Maugeri, Marek Zembala, et al.. (2007). Risk of Wheezing Associated with House-dust Mite Allergens and Indoor Air Quality Among Three-year-old Children. Kraków Inner City Study. International Journal of Occupational Medicine and Environmental Health. 20(2). 117–26. 8 indexed citations
5.
Szaflarska, Anna, Maciej Siedlar, & Marek Zembala. (2004). Human monocytes/macrophages in the antitumour response of the host. Central European Journal of Immunology. 28(2). 88–103. 2 indexed citations
6.
Siedlar, Maciej, Marion Frankenberger, Terje Espevik, et al.. (2004). Tolerance Induced by the Lipopeptide Pam3Cys Is Due to Ablation of IL-1R-Associated Kinase-1. The Journal of Immunology. 173(4). 2736–2745. 55 indexed citations
7.
Szaflarska, Anna, Monika Baj‐Krzyworzeka, Maciej Siedlar, et al.. (2004). Antitumor response of CD14+/CD16+ monocyte subpopulation. Experimental Hematology. 32(8). 748–755. 80 indexed citations
8.
Popiela, Tadeusz, Jan Kulig, Antoni Czupryna, Antoni Szczepanik, & Marek Zembala. (2004). Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Gastric Cancer. 7(4). 240–245. 34 indexed citations
9.
10.
Baran, Jarosław, Monika Baj‐Krzyworzeka, Kazimierz Węglarczyk, Irena Ruggiero, & Marek Zembala. (2004). Modulation of monocyte–tumour cell interactions by Mycobacterium vaccae. Cancer Immunology Immunotherapy. 53(12). 1127–1134. 11 indexed citations
11.
Mytar, Bożenna, et al.. (1999). Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity. British Journal of Cancer. 79(5-6). 737–743. 55 indexed citations
12.
Mytar, Bożenna, et al.. (1995). Monocyte - Mediated Regulation of Antigen - Driven IFNgamma Production by T Cells. The Role of Endogenously Produced TNF. Immunological Investigations. 24(6). 897–906. 4 indexed citations
13.
Blackstock, Rebecca, Marek Zembala, & G L Asherson. (1991). Functional equivalence of cryptococcal and haptene-specific T suppressor factor (TsF). Cellular Immunology. 136(2). 448–461. 9 indexed citations
14.
Little, Jeff, G. L. Asherson, Vittorio Colizzi, & Marek Zembala. (1988). Aα and Aβ class II I-A determinants of antigen-specific T-helper factor and its antigen-nonbinding chain. Cellular Immunology. 113(2). 404–413.
17.
Zembala, Marek, et al.. (1981). Inhibition of Contact Sensitivity by Macrophages. International Archives of Allergy and Immunology. 65(2). 121–128. 23 indexed citations
18.
Zembala, Marek, et al.. (1980). Inhibition of afferent phase of contact-sensitivity by macrophage-bound specific suppressor factor. Immunology Letters. 1(6). 307–309. 3 indexed citations
19.
Ptak, W, Marek Zembala, & Richard K. Gershon. (1978). Intermediary role of macrophages in the passage of suppressor signals between T-cell subsets.. The Journal of Experimental Medicine. 148(2). 424–434. 78 indexed citations
20.
Asherson, G L, A. C. Allison, & Marek Zembala. (1972). Production of delayed hypersensitivity by antigen associated with peritoneal exudate cells and the effect of pretreatment with Freund's complete adjuvant.. PubMed Central. 22(3). 465–73. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026